EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cancer Incidence and Outcomes After Kidney Transplantation in Balkan Nephropathy Patients

Matko Prtorić, Armin Atić iD, Bojan Jelaković iD, Željko Kaštelan, Nikolina Bašić-Jukić iD

Journal of Clinical Medicine · 12.08.2026 · 15 (16) · 6226

DOI: 10.3390/jcm15166226 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 12.08.2026. Verfasst von Matko Prtorić und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, University of Zagreb, 10000 Zagreb, Croatia. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Balkan nephropathy (BEN), caused by chronic dietary exposure to aristolochic acid (AA), is a tubulointerstitial kidney disease strongly associated with upper-tract urothelial carcinoma (UTUC). Patient and graft survival, the cumulative incidence and timing of post-transplant UTUC, and the burden of non-urothelial malignancy after kidney transplantation remain poorly defined.

Methods

We retrospectively analyzed all patients with BEN as the primary cause of end-stage kidney disease transplanted at University Hospital Center Zagreb between October 1973 and December 2023. Outcomes included patient and graft survival, the incidence and timing of post-transplant UTUC, and burden of non-urothelial malignancies.

Results

Of 2282 kidney transplants performed in the study period, 44 (2%) were in patients with BEN. The median age at transplantation was 56 years, and the median dialysis vintage was 3.7 years. After 10 years (median) of follow up, among 34 patients with adequate follow-up, 16 (47%) developed a de novo malignancy: eight (24%) UTUC, one renal cell carcinoma, four other solid tumors, and three hematological. UTUC was diagnosed between 6 months and 15 years post-transplant (median 7 years); five of eight patients died within one year of diagnosis. Five- and ten-year patient survival rates were 82% and 54.5%.

Conclusions

Kidney transplantation in patients with BEN carries a lifelong cancer risk dominated by UTUC. Prophylactic bilateral nephroureterectomy should be the default management strategy when feasible, with lifelong surveillance extending beyond the urothelium.

Schlagwörter

Stichwörter der Autor:innen

Balkan nephropathyaristolochic acidkidney transplantationlong-term survivalurothelial carcinoma

Autor:innen und Institutionen

  • School of Medicine, University of Zagreb, 10000 Zagreb, Croatia.
  • Department of Nephrology, Arterial Hypertension, Dialysis and Transplantation, University Hospital Center Zagreb, 10000 Zagreb, Croatia.
  • Urology Clinic, University Hospital Center Zagreb, 10000 Zagreb, Croatia.

ORCID-Profile: Armin Atić, Bojan Jelaković, Nikolina Bašić-Jukić

Zitieren

APA

Prtorić, M., Atić, A., Jelaković, B., Kaštelan, Ž., & Bašić-Jukić, N. (2026). Cancer Incidence and Outcomes After Kidney Transplantation in Balkan Nephropathy Patients. Journal of Clinical Medicine, 15(16), 6226. https://doi.org/10.3390/jcm15166226

Vancouver

Prtorić M, Atić A, Jelaković B, Kaštelan Ž, Bašić-Jukić N. Cancer Incidence and Outcomes After Kidney Transplantation in Balkan Nephropathy Patients. Journal of Clinical Medicine. 2026;15(16):6226. doi:10.3390/jcm15166226

BibTeX
@article{Prtori2026,
  author = {Prtorić, Matko and Atić, Armin and Jelaković, Bojan and Kaštelan, Željko and Bašić-Jukić, Nikolina},
  title = {Cancer Incidence and Outcomes After Kidney Transplantation in Balkan Nephropathy Patients},
  journal = {Journal of Clinical Medicine},
  year = {2026},
  volume = {15},
  number = {16},
  pages = {6226},
  doi = {10.3390/jcm15166226}
}
Kostenlos starten →